Dr Richard Russell
Senior Clinical Research Fellow
- Consultant Respiratory Physician
- Clinical Director Hampshire Integrated Respiratory Service
- Editor in Chief, International Journal of COPD
Past, present and future
Dr Russell graduated in Medicine from Guy's Hospital London. He underwent postgraduate training at Bart's and St George's Hospitals before returning to Guy's to undertake higher specialist training in Respiratory Medicine. He also trained at the Royal Brompton Hospital. His research interests began with a PhD at Imperial College under the supervision of Professor Peter Barnes. This was looking at basic mechanisms of COPD and matrix degradation. He completed his respiratory training and was then a Consultant Physician at Wexham Park Hospital.
Dr Russell is now a Consultant Physician at Lymington New Forest Hospital and is the Clinical Director of the Hampshire Community Integrated Respiratory Service, responsible for asthma and COPD care in community. He is also a PI in Experimental Medicine in the Respiratory Medicine Department at Oxford. His research interests are the basic mechanisms of COPD and asthma and how this leads to new therapeutic possibilities.
Dr Russell is the founding Editor of the International Journal of COPD.
He hopes that the future will bring an end to the curse of tobacco on our world and better treatments for those afflicted with the under-recognised and treated disease that is COPD.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Yu L-M. et al, (2021), The Lancet
Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
Yu L-M. et al, (2021)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S. et al, (2021), The Lancet. Respiratory medicine
Predicting treatment outcomes following an exacerbation of airways disease.
Halner A. et al, (2021), PloS one, 16
Finding the true prevalence of obstructive lung disease: two steps forward and one step back
Russell REK. and Wang K., (2020), European Respiratory Journal, 55, 2001514 - 2001514